The global Cardiac Implantable Electronic Device Market Growth Accelerated by Remote Monitoring Services
Cardiac Implantable Electronic Device (CIED) are implantable
medical devices that monitor and treat cardiac arrhythmias or abnormalities in
heart rate and rhythm. CIED such as pacemakers, implantable cardioverter
defibrillators (ICD) and cardiac resynchronization therapy (CRT) deliver
electrical therapy such as pacing pulses or defibrillation shocks to regulate
abnormal heart rhythms. With increase in chronic diseases due to lifestyle
changes and growing geriatric population, the demand for CIED is increasing.
The global Cardiac Implantable Electronic Device Market is
estimated to be valued at US$ 32.38 Mn in 2024 and is expected to exhibit a CAGR of 2.2% over the forecast period
2024 to 2031, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The rising adoption of remote monitoring services for CIED devices is one of
the key trends driving the cardiac
implantable electronic device market growth. Remote monitoring enables
continuous data collection of patient’s device and heart condition transmitted
through secure connection. This allows timely detection of any issues and
prevent hospital visits. It also helps physician to take corrective measures
proactively. During the ongoing COVID-19 pandemic, remote monitoring gained
significant importance as it reduces exposure risks for high-risk cardiac
patients. Going forward, major players are focusing on development of
innovative remote monitoring platforms integrated with analytics capabilities
which is expected to further accelerate the market growth over the forecast
period.
Segment Analysis
The global
Cardiac Implantable Electronic Device market is dominated by the pacemakers
sub-segment, which accounts for over 30% share of the overall market.
Pacemakers are the most widely used cardiac implantable electronic devices
owing to the rising prevalence of arrhythmias and technological advancements in
pacemaker technology. Integrated pacemakers that combine cardiac
resynchronization therapy, implantable cardioverter defibrillators, and
pacemaker functions into single devices are gaining popularity.
Key Takeaways
The global Cardiac Implantable Electronic Device market is expected to
witness high growth over the forecast period of 2024 to 2031. Rapidly aging
populations and the subsequent rise in cardiovascular diseases across major
markets will drive the demand for cardiac implantable electronic devices. The
global Cardiac Implantable Electronic Device Market is estimated to be valued
at US$ 32.38 Mn in 2024 and is expected to exhibit a CAGR of 2.2% over the forecast period 2024 to 2031.
Regional analysis
North America currently dominates the global market and is expected to maintain
its leading position during the forecast period as well. This can be attributed
to the high penetration of cardiac implantable devices and availability of
favorable reimbursement policies in the region. Meanwhile, the Asia Pacific
region is poised to witness the fastest growth due to growing healthcare
expenditures, rising awareness regarding cardiac devices, and improving access
to healthcare facilities.
Key players
Key players operating in the Cardiac Implantable Electronic Device market are
Boston Scientific Corporation, GlaxoSmithKline plc., Johnson & Johnson,
Viatris, and Medtronic Plc. Boston Scientific holds the leading market share
owing to its robust product portfolio and global sales network. Medtronic also
has a significant presence with its broad range of pacemakers, implantable
cardioverter defibrillators, and cardiac resynchronization therapy devices.
Get
more insights on this topic: https://www.newsstatix.com/cardiac-implantable-electronic-device-market-share-and-opportunity-analysis/
Comments
Post a Comment